IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Switzerland

  • ID: 1408498
  • Report
  • Region: Switzerland
  • 51 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. Healthcare System
Facts & Figures
Market Indicators
Provision & Funding
Compulsory Health Insurance
Complementary Health Insurance
Regulation and Funding
Ambulatory and Hospital Care

2. Pricing
Prescription Drugs
Applications
Decision
Equivalent Drugs
Innovation Bonus
International Price Comparison
Timelines
Price Reviews
Generic Drugs
Current Process
Proposed Changes
Price Reviews
Hospital Drugs
OTC Drugs

3. Reimbursement
Admission to Reimbursement
Swissmedic Classifications
Applications
Procedure
Decision
Reimbursement Restrictions
Reimbursement Categories
Reimbursement Prices
Hospital Reimbursement
Formularies
Funding
Changes in Reimbursement Status
Triennial Reviews
Health 2020 Reviews
Changes in Reimbursement Prices
Background
Price Increases
Triennial Reviews
Patent Expiry Reviews
Exceptional Reviews
Indication Extension Reviews
New Dosages/Pack Sizes
Other Price Cuts

4. Pharmacoeconomics
Pharmacoeconomic Requirements
Swiss Medical Board
Health 2020 Reviews

5. Price Build Up
Wholesalers
Margins
Discounts
Background
Retail Pharmacies
Margins
Fee-for-service Payments
Generic Substitution Fees
Per-pack Discount
Background
Recent Changes
NetCare
Mail Order/e-Pharmacy
Dispensing Doctors
Sales Tax

6. Cost Containment
Industry Paybacks
Per-pack Tax
Three-year Reviews
Promotional Costs
Patient Co-payments
Healthcare
Pharmaceuticals
Co-payment Exemptions
Complementary Private Insurance
Prescribing Controls
Monitoring
Quality Circles
Swiss Medical Board
E-prescribing
Generics
Rx-to-OTC Switches
Parallel Trade

7. Future Developments
Outlook
Pricing
Triennial Reviews
Patent Expiry Reviews
Reference Price Reimbursement System
Health Insurance Premiums
Health 2020
E-Health Initiatives
Hospital Funding
Rare Diseases
Pharmacies
Transparency Measures
TARMED

8. Names & Addresses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll